8.24

0.73% 0.06

After Hours: 8.24

Precision Biosciences Inc (DTIL)

Overview News Price History Option Chain Financials Discussions Forecast

Precision Biosciences Inc stock is traded at $8.24, with a volume of 424.62K. It is up +0.73% in the last 24 hours and up +26.77% over the past month. Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Previous Close:

$8.18

Open:

$7.95

24h Volume:

424.62K

Relative Volume:

1.24

Market Cap:

$212.61M

Revenue:

$34.26M

Net Income/Loss:

$-46.61M

P/E Ratio:

-1.5905

EPS:

-5.1806

Net Cash Flow:

$-62.01M

1W Performance:

+4.04%

1M Performance:

+26.77%

6M Performance:

+95.72%

1Y Performance:

+89.86%

1-Day Range:

$7.95

$8.53

1-Week Range:

$7.55

$8.53

52-Week Range:

$3.53

$8.82

Precision Biosciences Inc Stock (DTIL) Company Profile

Name

Precision Biosciences Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

919-314-5512

Address

302 EAST PETTIGREW STREET, DURHAM, NC

Employee

Twitter

@PrecisionBioSci

Next Earnings Date

2026-08-06

Latest SEC Filings

DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DTIL Precision Biosciences Inc	8.24	202.81M	34.26M	-46.61M	-62.01M	-5.1806
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	BMO Capital Markets	Market Perform → Outperform
Apr-30-24	Initiated	Guggenheim	Buy
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-09-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-27-20	Resumed	BTIG Research	Buy
Apr-03-20	Downgrade	Goldman	Buy → Neutral
Mar-05-20	Initiated	Stifel	Buy
Feb-25-20	Initiated	William Blair	Outperform
Aug-09-19	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	H.C. Wainwright	Buy
Apr-22-19	Initiated	Barclays	Overweight
Apr-22-19	Initiated	Goldman	Buy
Apr-22-19	Initiated	JP Morgan	Overweight
Apr-22-19	Initiated	Jefferies	Buy

View All

Precision Biosciences Inc Stock (DTIL) Latest News

Jul 01, 2026

Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing - Minichart

Jul 01, 2026

Precision BioSciences Advances Gene-Editing Programs in Hepatitis B - TipRanks

Jul 01, 2026

Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline - Stock Titan

Jul 01, 2026

Jun 29, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Precision BioSciences added to Russell 2000 index - Investing.com

Jun 29, 2026

Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential - GuruFocus

Jun 29, 2026

Index Expanding Market Visibility with Institutional Investors - Business Wire

Jun 29, 2026

Jun 28, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2500 Index - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0) - TradingView

Jun 26, 2026

Price to sales forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Jun 26, 2026